Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings.

Robert P. Hartman, Murali Sundaram, Scott Heitaka Okuno, Franklin H. Sim

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVE: Our goal was to determine the incidence and pattern of red marrow reconversion on MRI of adults receiving granulocyte-stimulating factors as part of their chemotherapy regimen for primary musculoskeletal neoplasms and correlate the changes with WBC counts. MATERIALS AND METHODS: Twenty-five adults with soft-tissue sarcomas (n = 15) or primary bone tumors (n = 10) who underwent chemotherapy that included granulocyte-stimulating factors formed the study group. Two radiologists retrospectively evaluated the MRI studies by consensus before and after therapy to determine the presence of changes consistent with red marrow reconversion. Changes were categorized by appearance on T1- and T2-weighted images for location, pattern, and extent of marrow involvement. WBC counts at the time of MRI were recorded. Records were examined for evidence of marrow-infiltrating tumors or metastases. RESULTS: Ten (40%) of the 25 patients underwent bone marrow changes consistent with red marrow reconversion. In seven (70%) of 10 patients, the changes were diffuse in visualized bones and simulated diffuse marrow-infiltrative tumor. In three (30%) of 10 patients, the changes were focal, simulating metastases. T2 signal prolongation was identified in the marrow reconversion in nine patients (90%), although all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, but all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, five (50%) had normal counts, and one (10%) had a below-normal count. No osseous metastases or marrow-infiltrating tumors were found during follow-up. CONCLUSION: Forty percent of patients showed marrow changes mimicking tumor on MRI that were attributable to red marrow reconversion, which correlated moderately with WBC response.

Original languageEnglish (US)
Pages (from-to)645-653
Number of pages9
JournalAJR. American journal of roentgenology
Volume183
Issue number3
StatePublished - Sep 2004

Fingerprint

Granulocytes
Bone Marrow
Incidence
Neoplasms
Neoplasm Metastasis
Bone and Bones
Drug Therapy
Sarcoma
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies : incidence and MRI findings. / Hartman, Robert P.; Sundaram, Murali; Okuno, Scott Heitaka; Sim, Franklin H.

In: AJR. American journal of roentgenology, Vol. 183, No. 3, 09.2004, p. 645-653.

Research output: Contribution to journalArticle

@article{674715e7fc824cfc94edbd68a5b54417,
title = "Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings.",
abstract = "OBJECTIVE: Our goal was to determine the incidence and pattern of red marrow reconversion on MRI of adults receiving granulocyte-stimulating factors as part of their chemotherapy regimen for primary musculoskeletal neoplasms and correlate the changes with WBC counts. MATERIALS AND METHODS: Twenty-five adults with soft-tissue sarcomas (n = 15) or primary bone tumors (n = 10) who underwent chemotherapy that included granulocyte-stimulating factors formed the study group. Two radiologists retrospectively evaluated the MRI studies by consensus before and after therapy to determine the presence of changes consistent with red marrow reconversion. Changes were categorized by appearance on T1- and T2-weighted images for location, pattern, and extent of marrow involvement. WBC counts at the time of MRI were recorded. Records were examined for evidence of marrow-infiltrating tumors or metastases. RESULTS: Ten (40{\%}) of the 25 patients underwent bone marrow changes consistent with red marrow reconversion. In seven (70{\%}) of 10 patients, the changes were diffuse in visualized bones and simulated diffuse marrow-infiltrative tumor. In three (30{\%}) of 10 patients, the changes were focal, simulating metastases. T2 signal prolongation was identified in the marrow reconversion in nine patients (90{\%}), although all had shortened T1 signal. Four patients (40{\%}) had elevated WBC counts at the time of the MRI after therapy, but all had shortened T1 signal. Four patients (40{\%}) had elevated WBC counts at the time of the MRI after therapy, five (50{\%}) had normal counts, and one (10{\%}) had a below-normal count. No osseous metastases or marrow-infiltrating tumors were found during follow-up. CONCLUSION: Forty percent of patients showed marrow changes mimicking tumor on MRI that were attributable to red marrow reconversion, which correlated moderately with WBC response.",
author = "Hartman, {Robert P.} and Murali Sundaram and Okuno, {Scott Heitaka} and Sim, {Franklin H.}",
year = "2004",
month = "9",
language = "English (US)",
volume = "183",
pages = "645--653",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",

}

TY - JOUR

T1 - Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies

T2 - incidence and MRI findings.

AU - Hartman, Robert P.

AU - Sundaram, Murali

AU - Okuno, Scott Heitaka

AU - Sim, Franklin H.

PY - 2004/9

Y1 - 2004/9

N2 - OBJECTIVE: Our goal was to determine the incidence and pattern of red marrow reconversion on MRI of adults receiving granulocyte-stimulating factors as part of their chemotherapy regimen for primary musculoskeletal neoplasms and correlate the changes with WBC counts. MATERIALS AND METHODS: Twenty-five adults with soft-tissue sarcomas (n = 15) or primary bone tumors (n = 10) who underwent chemotherapy that included granulocyte-stimulating factors formed the study group. Two radiologists retrospectively evaluated the MRI studies by consensus before and after therapy to determine the presence of changes consistent with red marrow reconversion. Changes were categorized by appearance on T1- and T2-weighted images for location, pattern, and extent of marrow involvement. WBC counts at the time of MRI were recorded. Records were examined for evidence of marrow-infiltrating tumors or metastases. RESULTS: Ten (40%) of the 25 patients underwent bone marrow changes consistent with red marrow reconversion. In seven (70%) of 10 patients, the changes were diffuse in visualized bones and simulated diffuse marrow-infiltrative tumor. In three (30%) of 10 patients, the changes were focal, simulating metastases. T2 signal prolongation was identified in the marrow reconversion in nine patients (90%), although all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, but all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, five (50%) had normal counts, and one (10%) had a below-normal count. No osseous metastases or marrow-infiltrating tumors were found during follow-up. CONCLUSION: Forty percent of patients showed marrow changes mimicking tumor on MRI that were attributable to red marrow reconversion, which correlated moderately with WBC response.

AB - OBJECTIVE: Our goal was to determine the incidence and pattern of red marrow reconversion on MRI of adults receiving granulocyte-stimulating factors as part of their chemotherapy regimen for primary musculoskeletal neoplasms and correlate the changes with WBC counts. MATERIALS AND METHODS: Twenty-five adults with soft-tissue sarcomas (n = 15) or primary bone tumors (n = 10) who underwent chemotherapy that included granulocyte-stimulating factors formed the study group. Two radiologists retrospectively evaluated the MRI studies by consensus before and after therapy to determine the presence of changes consistent with red marrow reconversion. Changes were categorized by appearance on T1- and T2-weighted images for location, pattern, and extent of marrow involvement. WBC counts at the time of MRI were recorded. Records were examined for evidence of marrow-infiltrating tumors or metastases. RESULTS: Ten (40%) of the 25 patients underwent bone marrow changes consistent with red marrow reconversion. In seven (70%) of 10 patients, the changes were diffuse in visualized bones and simulated diffuse marrow-infiltrative tumor. In three (30%) of 10 patients, the changes were focal, simulating metastases. T2 signal prolongation was identified in the marrow reconversion in nine patients (90%), although all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, but all had shortened T1 signal. Four patients (40%) had elevated WBC counts at the time of the MRI after therapy, five (50%) had normal counts, and one (10%) had a below-normal count. No osseous metastases or marrow-infiltrating tumors were found during follow-up. CONCLUSION: Forty percent of patients showed marrow changes mimicking tumor on MRI that were attributable to red marrow reconversion, which correlated moderately with WBC response.

UR - http://www.scopus.com/inward/record.url?scp=4644244329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644244329&partnerID=8YFLogxK

M3 - Article

C2 - 15333351

AN - SCOPUS:4644244329

VL - 183

SP - 645

EP - 653

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 3

ER -